These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. microRNA-mediated differential expression of TRMU, GTPBP3 and MTO1 in cell models of mitochondrial-DNA diseases. Meseguer S; Boix O; Navarro-González C; Villarroya M; Boutoual R; Emperador S; García-Arumí E; Montoya J; Armengod ME Sci Rep; 2017 Jul; 7(1):6209. PubMed ID: 28740091 [TBL] [Abstract][Full Text] [Related]
23. [Diseases of the human mitochondrial oxidative phosphorylation system]. Ruiz-Pesini E; López-Gallardo E; Dahmani Y; Herrero MD; Solano A; Díez-Sánchez C; López-Pérez M; Montoya J Rev Neurol; 2006 Oct 1-15; 43(7):416-24. PubMed ID: 17006861 [TBL] [Abstract][Full Text] [Related]
24. Unmasking the causes of multifactorial disorders: OXPHOS differences between mitochondrial haplogroups. Gómez-Durán A; Pacheu-Grau D; López-Gallardo E; Díez-Sánchez C; Montoya J; López-Pérez MJ; Ruiz-Pesini E Hum Mol Genet; 2010 Sep; 19(17):3343-53. PubMed ID: 20566709 [TBL] [Abstract][Full Text] [Related]
25. An introduction: oxidative phosphorylation diseases. Shoffner JM Semin Neurol; 2001 Sep; 21(3):237-50. PubMed ID: 11641814 [TBL] [Abstract][Full Text] [Related]
26. Differences in assembly or stability of complex I and other mitochondrial OXPHOS complexes in inherited complex I deficiency. Ugalde C; Janssen RJ; van den Heuvel LP; Smeitink JA; Nijtmans LG Hum Mol Genet; 2004 Mar; 13(6):659-67. PubMed ID: 14749350 [TBL] [Abstract][Full Text] [Related]
27. The transmission of OXPHOS disease and methods to prevent this. Jacobs LJ; de Wert G; Geraedts JP; de Coo IF; Smeets HJ Hum Reprod Update; 2006; 12(2):119-36. PubMed ID: 16199488 [TBL] [Abstract][Full Text] [Related]
28. Nuclear genes involved in mitochondrial diseases caused by instability of mitochondrial DNA. Rusecka J; Kaliszewska M; Bartnik E; Tońska K J Appl Genet; 2018 Feb; 59(1):43-57. PubMed ID: 29344903 [TBL] [Abstract][Full Text] [Related]
30. Mitochondria: mitochondrial OXPHOS (dys) function ex vivo--the use of primary fibroblasts. Saada A Int J Biochem Cell Biol; 2014 Mar; 48():60-5. PubMed ID: 24412346 [TBL] [Abstract][Full Text] [Related]
31. In vitro treatment of HepG2 cells with saturated fatty acids reproduces mitochondrial dysfunction found in nonalcoholic steatohepatitis. García-Ruiz I; Solís-Muñoz P; Fernández-Moreira D; Muñoz-Yagüe T; Solís-Herruzo JA Dis Model Mech; 2015 Feb; 8(2):183-91. PubMed ID: 25540128 [TBL] [Abstract][Full Text] [Related]
32. Depletion of the other genome-mitochondrial DNA depletion syndromes in humans. Elpeleg O; Mandel H; Saada A J Mol Med (Berl); 2002 Jul; 80(7):389-96. PubMed ID: 12110944 [TBL] [Abstract][Full Text] [Related]
33. The clinical diagnosis of POLG disease and other mitochondrial DNA depletion disorders. Cohen BH; Naviaux RK Methods; 2010 Aug; 51(4):364-73. PubMed ID: 20558295 [TBL] [Abstract][Full Text] [Related]
34. Mitochondrial disorders. Zeviani M; Di Donato S Brain; 2004 Oct; 127(Pt 10):2153-72. PubMed ID: 15358637 [TBL] [Abstract][Full Text] [Related]
35. The pathophysiology of mitochondrial biogenesis: towards four decades of mitochondrial DNA research. Fernández-Moreno MA; Bornstein B; Petit N; Garesse R Mol Genet Metab; 2000 Nov; 71(3):481-95. PubMed ID: 11073716 [TBL] [Abstract][Full Text] [Related]